Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for renal disorders.

Yeong-Hau H Lien1, Li-Wen Lai

  • 1University of Arizona Health Sciences Center, Section of Nephrology, Department of Medicine, Tucson, AZ 85724, USA. lien@u.arizona.edu

Expert Opinion on Biological Therapy
|June 4, 2004
PubMed
Summary

Gene therapy offers new hope for treating kidney diseases, with several promising methods like viral vectors and RNA interference showing potential in animal studies for future human applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is it Time to Set a 25% Decrease in eGFR as Criteria for Community-Acquired Acute Kidney Injury in Primary Care Clinics?

The American journal of medicine·2024
Same author

Stomatitis and Bone Marrow Suppression Followed by Leukoerythroblastosis in a Patient on Long-Term Low-Dose Methotrexate Therapy.

The American journal of medicine·2022
Same author

Digenic Inheritance of a FOXC2 Mutation and Two PIEZO1 Mutations Underlies Congenital Lymphedema in a Multigeneration Family.

The American journal of medicine·2021
Same author

Sustained Release GLP-1 Agonist PT320 Delays Disease Progression in a Mouse Model of Parkinson's Disease.

ACS pharmacology & translational science·2021
Same author

Rare monosomy 7 and deletion 7p at diagnosis of chronic myeloid leukemia in accelerated phase.

Cancer genetics·2021
Same author

Exome sequencing in patients with microphthalmia, anophthalmia, and coloboma (MAC) from a consanguineous population.

Clinical genetics·2020

Area of Science:

  • Nephrology
  • Molecular Biology
  • Biotechnology

Background:

  • Significant advancements in renal replacement therapies like dialysis and transplantation have been made.
  • Despite progress, treatment options for many renal diseases remain limited.

Purpose of the Study:

  • To review recent data on gene therapy in animal models relevant to human renal diseases.
  • To evaluate the efficacy, safety, and clinical relevance of gene therapy approaches for kidney disorders.

Main Methods:

  • Review of current literature on gene therapy techniques in preclinical renal disease models.
  • Analysis of various gene delivery systems including viral vectors, electroporation, and RNA interference.

Main Results:

  • Several gene therapy approaches demonstrate promise in animal models.
  • Adeno-associated viral vectors show potential for long-term gene expression.
  • Electroporation, ultrasound/microbubble-mediated targeting, macrophage-based delivery, and small interfering RNAs are also highlighted.

Conclusions:

  • Gene therapy represents a potential future treatment modality for various renal diseases.
  • Further research and validation in animal models are crucial for clinical translation.
  • Promising gene therapy strategies warrant continued investigation for kidney disease treatment.

Related Experiment Videos